A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

Basit Öğe Kaydı
dc.authoridErkurt, Mehmet Ali/0000-0002-3285-417X
dc.authoridBasturk, Abdulkadir/0000-0003-1864-0316
dc.authoridSARICI, Ahmet/0000-0002-5916-0119
dc.authorwosidUlas, Turgay TU/A-6050-2018
dc.authorwosidKorkmaz, Serdal/IST-3736-2023
dc.authorwosidErkurt, Mehmet Ali/ABI-7232-2020
dc.authorwosidBasturk, Abdulkadir/B-1962-2018
dc.authorwosidSARICI, Ahmet/ABI-7512-2020
dc.contributor.authorBasturk, Abdulkadir
dc.contributor.authorSayin, Serhat
dc.contributor.authorErkurt, Mehmet Ali
dc.contributor.authorSarici, Ahmet
dc.contributor.authorEkinci, Omer
dc.contributor.authorKum, Asli
dc.contributor.authorBerber, Ilhami
dc.date.accessioned2024-08-04T20:50:34Z
dc.date.available2024-08-04T20:50:34Z
dc.date.issued2021
dc.departmentİnönü Üniversitesien_US
dc.description.abstractImmune Thrombocytopenia (ITP) is an autoimmune disease characterized by thrombocytopenia and skin and mucosal bleeding. In patients with an indication for treatment, corticosteroids, intravenous immunoglobulin (IVIg) and anti-D are recommended as the first line, while splenectomy, thrombopoietin receptor agonists or rituximab are recommended second line options. Approximately 10 % of adult patients with ITP fall into the chronic refractory ITP group. Therapeutic plasma exchange (TPE) has generally been tested in patients with refractory ITP, who have failed to respond to conventional treatments, in case of bleeding or prior to surgical interventions. It has been stated that elimination of the antibodies that are held responsible in the pathogenesis of the disease has an effective role in the treatment. In this article, we present the results of 17 patients, who underwent TPE for refractory ITP, together with the literature data.en_US
dc.identifier.doi10.1016/j.transci.2021.103246
dc.identifier.issn1473-0502
dc.identifier.issn1878-1683
dc.identifier.issue5en_US
dc.identifier.pmid34419359en_US
dc.identifier.scopus2-s2.0-85113139327en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.1016/j.transci.2021.103246
dc.identifier.urihttps://hdl.handle.net/11616/100146
dc.identifier.volume60en_US
dc.identifier.wosWOS:000697004600013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofTransfusion and Apheresis Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectImmune thrombocytopeniaen_US
dc.subjectRefractoryen_US
dc.subjectTherapeutic plasma exchangeen_US
dc.subjectAnalysisen_US
dc.titleA multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpuraen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu